LSA
ABMD

Leonteq Securities AG’s Abiomed Inc ABMD Stock Holding History

Leonteq Securities AG’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-973
Closed -$239K – 1384
2022
Q3 		$239K Sell
973
-200
-17% -$54K 0.01% 496
2022
Q2 		$290K Buy
1,173
+98
+9% +$26.4K 0.01% 485
2022
Q1 		$356K Sell
1,075
-471
-30% -$145K 0.01% 480
2021
Q4 		$555K Sell
1,546
-126
-8% -$42.6K 0.02% 441
2021
Q3 		$544K Buy
1,672
+209
+14% +$70.8K 0.02% 404
2021
Q2 		$457K Sell
1,463
-470
-24% -$144K 0.03% 397
2021
Q1 		$616K Sell
1,933
-518
-21% -$166K 0.04% 350
2020
Q4 		$795K Buy
+2,451
New +$678K 0.04% 319

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Leonteq Securities AG's ABMD Position: Q4 2022 in Review

Leonteq Securities AG sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 973 shares — an estimated $239K sold.

Leonteq Securities AG first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $795K in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Leonteq Securities AG reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Leonteq Securities AG sold 973 Abiomed Inc shares in Q4 2022, an estimated $239K.
  • Leonteq Securities AG first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • Leonteq Securities AG's Abiomed Inc position peaked at $795K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Leonteq Securities AG's 13F filing for Q4 2022, filed 26 Mar 2026.